Filter the stock market quickly and confidently. With hundreds of financial measures ready to use, you can build stock screens to find shares to match any investment style.
Ready to create your own screen?
Try stockopedia free for 14 daysWe go to great lengths to ensure our financial and technical data is the most current and accurate information possible.
Get complete clarity with flexible viewing options that let you to see the information that is important to you.
Stock screens save you time that can be better spent researching fewer stocks that meet your criteria.
After your free trial, plans start at just £295 per year. With a one month money back guarantee, you're in control.
Whether you are looking for value, momentum or income opportunities we give you more than 65 pre-programmed "GuruScreens" to kick-start your search. We've curated the stock screener criteria of the greatest investment experts of all time saving you time and hassle in your hunt for winning investments.
Quickly compare the performance of different screening strategies. With the historic performance of each Guru strategy clearly displayed, you can see what investment styles work and what does not under different market conditions.
Build rules to compare stocks against their market and industry averages. Rank sectors by any data point - from simple fields like the Yield and P/E to complex composite measures like the Piotroski F Score or Altman Z-Score to assess financial health.
Name | P/E | Mrkt Cap | F-Score | |
---|---|---|---|---|
Symphony International Holdings | 3.8 | £270m | 7 | |
Glaxosmithkline | 11.7 | £74,873m | 7 | |
Spire Healthcare | 6.7 | £465.3m | 6 | |
Md Medical Investments | 11.5 | £345.9m | 5 | |
Caretech Holdings | 9.9 | £386.5m | 5 | |
Indivior | 7.1 | £1,324m | 5 | |
Alliance Pharma | 13.1 | £342m | 5 | |
Puretech Health | 12.3 | £454.8m | 3 |
I can quickly access a share pool that meets my criteria.
It saves so much time; this analysis can be done so quickly.
I can literally decide in a few minutes whether I want to invest in it or not.
After your free trial, plans start at just £295 per year. With a one month money back guarantee, you're in control.
Powered by our proprietary institutional grade financial database, you can sift, sort and screen the market using hundreds of metrics. The data set includes the powerful StockRanks™ which assess the Quality, Value and Momentum of any share instantly. Ratios can be used on their own or combined to give you granular control over the stocks that are uncovered.
Filter for specific industries to plug diversification gaps in your portfolio, or restrict your search to specific exchanges or indices to find tax efficient investments. Our simple to use advanced filters provide unparalleled ways of slicing and dicing stock markets.
We help you drill deeper into the financial health of your shortlist with customisable data views. Tables can be edited to view any ratio in our database so you can view every company alongside the metrics you care about. At a glance you can isolate the best shares in the list. If numbers and ratios just aren’t your thing, results can be visualised through charts to help you spot trends and quickly identify opportunities.
After your free trial, plans start at just £295 per year. With a one month money back guarantee, you're in control.
Great investors use strict criteria, but strict criteria can exclude so many shares in an individual market that you may be left with no candidate stocks. Stockopedia provides a pan-global financial market database which opens up immense opportunity to even the strictest of investors. Any country or region can be added to expand your screening universe.
Stay on top of the changes in stock screens by tracking the promotions & demotions lists - updated daily before the open. Find opportunities before other investors.
Stockopedia is one of the few companies in the world that the markets giant Refinitiv (a Thomson Reuters company) partners with to serve the individual investor.
Stockopedia is the perfect solution for the time-poor individual investor looking for results
Plans start at just £295 per year
After your free trial, plans start at just £295 per year. With a one month money back guarantee, you're in control.